SOX2 and melanoma: We then conducted a MDR efflux assay and found that SOX2 silencing strongly counteracted the efflux activity of BCRP/ABCG2 transporter induced by PLX4032 in all BRAFV600E melanoma cells tested (Figs. 7, B and C and S11, A and B).